Clinical Outcome Review Programmes
About the Clinical Outcome Review Programmes
The Clinical Outcome Review Programmes which now encompass Confidential Enquiries are designed to help assess the quality of healthcare, and stimulate improvement in safety and effectiveness by systematically enabling clinicians, managers and policy makers to learn from adverse events and other relevant data. The programme aims to complement and contribute to the work of other agencies such as NICE; CQC, the Royal Colleges and academic research studies with the aim of supporting changes that can help improve the quality and safety of healthcare delivery.
There are four Clinical Outcome Review Programmes which are commissioned by HQIP on behalf of the Department of Health, England, NHSSPS Northern Ireland, NHS Scotland and NHS Wales, the Channel Islands and the Isle of Man.
Service provider contracts for these programmes were awarded in March 2011 to the following suppliers:
Management of the Confidential Outcome Review Programmes
As of 1 September 2011, HQIP is now responsible for the management and commissioning of the Clinical Outcome Review Programmes, previously the responsibility of the National Patient Safety Agency (NPSA). Note: These programmes are also known as Confidential Enquiries.
All enquiries relating to the programme should now be addressed directly to HQIP Clinical Outcome Review Programmes Business Manager Jenny Mooney (formerly holder of the same role at NPSA) via jenny.mooney@hqip.org.uk or 020 7469 2500.
The transfer includes the interim management of maternal and newborn data and the Maternal and Perinatal Mortality Notification (MPMN) web portal - http://www.mpmn.nhs.uk/ - and the MPMN Enquiries email - enquiries@mpmn.nhs.uk.
These will continue to operate as usual under the management of HQIP. There are no changes to the collection of maternal and newborn data (see below for more on this programme).
The moves are part of the recommendations of the Department of Health's ALB Review, published in 2010.